AMSTERDAM, May 30 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that positive interim data from its pivotal clinical trial with AMT's lead product Glybera(R) (AMT-011) were presented by the Principal Investigator, professor Daniel Gaudet, at the American Society of Gene Therapy Annual Meeting in Boston on May 29th. These data confirm the outcome of a previous study conducted in The Netherlands, demonstrating safety and efficacy of Glybera(R) for lipoprotein-lipase deficiency, a disease also known as Hyperlipoproteinemia (HPL) type I. Currently, there is no effective treatment or cure for this seriously debilitating and potentially lethal disease.

Study data

CANNES, France, May 30 /PRNewswire/ --

- New Portal from Long-Time Provider of Surveillance Data, Analytics, Software, and Content for the Global Securitisation Industry Supports ESF Initiatives to Promote Transparency

Global ABS 2008 -- Lewtan Technologies, Inc., provider of ABSNet, the industry's leading source for asset-backed securities surveillance data, analytics, software, and content for the global securitisation industry, today announced the availability of the Global ABS Portal, which provides free access to the most recent remittance reports and original prospectuses for public European securitisations.

TORONTO, May 30 /PRNewswire/ --

- Developer Plans To Catapult its Growth & Penetration of the Wind and Solar Industry

Canada's leading renewable energy developer, SkyPower Corp, a Lehman Brothers Company, announced today that it is considering strategic alternatives to augment its growing capital base and accelerate development of its wind and solar pipelines. The Company's portfolio of wind and solar projects -- in various stages of development and construction -- represents in excess of 10,000 MW of potential renewable energy.

Don't put a down payment on that invisible plane just yet but a team of scientists from Boston College and Duke University developed a highly-engineered metamaterial capable of absorbing all of the light that strikes it – to a scientific standard of perfection.

The metamaterial uses tiny geometric surface features to successfully capture the electric and magnetic properties of a microwave to the point of total absorption.

The group used computer simulations based on prior research findings in the field to design resonators able to couple individually to electric and magnetic fields to successfully absorb all incident radiation, according to the findings in Physical Review Letters..

SANTA CLARA, California, May 29 /PRNewswire/ --

Marvell Technology Group Ltd. (Nasdaq: MRVL), a leader in storage, communications, and consumer silicon solutions, today announced it has named Clyde R. Hosein Chief Financial Officer, effective June 23rd, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070411/SFW034LOGO)

EDMONTON, Canada, May 29 /PRNewswire/ --

- TCH (Taxotere, Carboplatin, Herceptin) showed a significant improvement in Disease-Free Survival (DFS) and Overall Survival (OS), compared to AC-T (doxorubicin and cyclophosphamide followed by docetaxel) and a 5-fold lower cardiotoxicity compared to AC-TH (AC-T + Herceptin) in women receiving adjuvant therapy for HER2-positive ESBC

LONDON, May 29 /PRNewswire/ --

Global Crossing (UK) Finance plc ("GCUK Finance"), a wholly owned subsidiary of Global Crossing Limited (Nasdaq: GLBC), announced today, May 29, 2008, the expiration of its excess cash offer with respect to its senior secured notes. The offer expired today at 5:00 p.m. BST.

EVANSTON, Illinois, May 29 /PRNewswire/ --

- Kellogg School of Management expert finds social equality leads to better math skills for women

The gender gap in math perceived to exist between girls and boys has long been contested. New research published in the journal Science sheds clarity on the debate and demonstrates that girls perform better in mathematics in more gender equal societies, in some cases besting male peers.

HAIFA, Israel, May 29 /PRNewswire/ --

- Recently Launched Campaign to Promote use of Euro 5 Transportation Fuel Standard

MOUNTAIN VIEW, California, May 29 /PRNewswire/ --

Silecs, Inc., a leading provider of advanced enabling materials to the microelectronics industry, today announced that its high-volume manufacturing facility in Espoo, Finland, has been granted ISO 14001 certification by DNV. This important recognition follows a rigorous review of Silecs' state-of-the-art facility, designed from the ground up to adhere to the highest possible standards for protecting the environment as well as the health and safety of Silecs' employees and customers.